About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

HIV Committing Suicide in Body Could Soon Become A Possibility

by Rukmani Krishna on September 21, 2013 at 11:31 PM
 HIV Committing Suicide in Body Could Soon Become A Possibility

A microbicide that can trick HIV into 'popping' itself into oblivion was created by researchers, including one of Indian origin.

Scientists from Drexel's College of Engineering; School of Biomedical Engineering, Science and Health Systems; and College of Medicine have named the microbicide DAVEI - which stands for 'Dual Action Virolytic Entry Inhibitor.'

Advertisement

Dr. Cameron Abrams, a professor in Drexel's College of Engineering and a primary investigator of the project, said that while several molecules that destroy HIV have recently been announced, DAVEI is unique among them by virtue of its design, specificity and high potency.

A team co-led by Abrams and Dr. Irwin Chaiken in the Department of Biochemistry and Molecular Biology in Drexel's College of Medicine, and including Dr. Mark Contarino and doctoral students Arangassery Rosemary Bastian and R. V. Kalyana Sundaram, developed the molecule assembled from pieces of other molecules and engineered for a specific purpose, in this case to fight HIV.
Advertisement

The idea behind DAVEI was to design a molecule that hijacks the virus's fusion machinery, the tools it uses to attach to and attack a healthy cell, and tricks the virus into destroying itself.

The team designed DAVEI from two main ingredients. One piece, called the Membrane Proximal External Region (MPER), is itself a small piece of the fusion machinery and interacts strongly with viral membranes. The other piece, called cyanovirin, binds to the sugar coating of the protein spike. Working together, the MPER and cyanovirin in DAVEI 'tweak' the fusion machinery in a way that mimics the forces it feels when attached to a cell.

The research is set to be published in the October edition of the American Society for Microbiology's Antimicrobial Agents and Chemotherapy.

Source: ANI
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest AIDS/HIV News

HIV Vaccine Clinical Trial Initiates in the United States and South Africa
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
Beauty Salon-Driven Initiative Boosts PrEP Awareness in Fight Against AIDS
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Immune-Evading HIV Protein Complex Solved
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Does Gender Influence Comorbidity Rates in HIV-Positive Smokers
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
Digital Test Measures HIV Viral Load
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

HIV Committing Suicide in Body Could Soon Become A Possibility Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests